Eric Lefkofsky: Tackling Innovation and Treating Cancer

Tempus labs run by Eric Lefkofsky is based out of Chicago. The technology firm that started in 2015 utilizes artificial intelligence to comprehend cancer diseases genetic algorithmic patterns. The organization’s goal is to clean up and basically digitized the health information on all patients with cancer giving doctors an opportunity to observe data and help those in the future. Tempus Labs has come up with what is called molecular data by using DNA/RNA sequencing. They use a list of data pipelines that cleanse, collect and analyze molecular and clinical information to ensure quality medicine.

The idea is to place all cancer patients data basically one place. This allows doctors to make decisions that are in real-time and based on the data for them to use on future patients. This information gives physicians an opportunity to learn about all patients diagnosed with cancer on an annual basis. When they can discover the treatment received by each patient they can make more informed decisions on the next patients that follow the current ones. The firm is among Chicago’s top 10 health technology firms. They have partnerships with various healthcare organizations, the National Cancer Institute-Designated Comprehensive Cancer Center and many Academic Institutions. Several of the anyhow oncologist refer patients to tempest to undergo genomic sequencing.

Eric Lefkofsky is known as a very influential entrepreneur throughout Chicago. He is the co-founder of many different well-known businesses. Those include Groupon, Lightbank, Uptake Technologies, Inner Workings and Echo Global Logistics, to name a few. His philanthropic efforts have been as a trustee of the the Art Institute of Chicago, a Trustee of the Lurie Children’s Hospital in Chicago, Industry and World Business Chicago and The Museum of Science. He it’s also the chairman of the board of Trustess’ for the Chicago Steppenwolf Theatre company. Eric Lefkofsky continue to be a member of the Giving Pledge since 2013. He is also and adjunct professor at the University of Chicago Booth School of Business. Further, until recently, he has become the author of his book called Accelerated Disruption: Understanding the true speed of innovation. He also continues spending his time researching new ways to treat cancer.

Nina

Leave a Reply